Ritlecitinib and its Impurities

Ritlecitinib is a small molecule, being developed by Pfizer, for the oral treatment of ulcerative colitis, alopecia areata, vitiligo, and Crohn's disease. Reference standards of Ritlecitinib API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.